This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffin, S. V. Articles by Shankland, S. J. Search for Related Content PubMed PubMed Citation Articles by Griffin, S. V. Articles by Shankland, S. J.

(American Journal of Pathology. 2004;165:1175-1185.)
© 2004 American Society for Investigative Pathology

Cyclin-Dependent Kinase 5 Is a Regulator of Podocyte Differentiation, Proliferation, and Morphology

Sin V. Griffin^*, Keiju Hiromura^*, Jeffrey Pippin^*, Arndt T. Petermann^*, Mary J. Blonski^*, Ron Krofft^*, Satoru Takahashi, Ashok B. Kulkarni and Stuart J. Shankland^*

From the Department of Medicine,^* Division of Nephrology, University of Washington School of Medicine, Seattle, Washington; and the Functional Genomics Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland

Podocytes are highly specialized and terminally differentiated glomerular cells that play a vital role in renal physiology, including the prevention of proteinuria. Cyclin-dependent kinase 5 (CDK5) has been shown to influence several cellular processes in other terminally differentiated cells, in particular neurons. In this study, we examined the role of CDK5 in podocyte differentiation, proliferation, and morphology. In conditionally immortalized mouse podocytes in culture, CDK5 increased in association with podocyte differentiation. During mouse glomerulogenesis in vivo, CDK5 expression was predominantly detected in podocytes from the capillary loop stage to maturation and persisted in the podocytes of adult glomeruli. In contrast, CDK5 was markedly decreased in the proliferating and dedifferentiated podocytes of mice with anti-glomerular basement membrane nephritis and in human immunodeficiency virus transgenic mice. p35, the activator of CDK5, was also detected in podocytes and the p35/CDK5 complex was active. Cell fractionation studies showed that active p35/CDK5 was mainly localized to the plasma membrane. Specific inhibition of CDK5 in differentiated cultured podocytes, either pharmacologically or with siRNA, induced shape changes, with cellular elongation and loss of process formation compared to the characteristic arborized phenotype. These data suggest a role for CDK5 as a regulator of podocyte differentiation, proliferation, and morphology.

This article has been cited by other articles:

				K.-H. Sun, Y. de Pablo, F. Vincent, E. O. Johnson, A. K. Chavers, and K. Shah Novel Genetic Tools Reveal Cdk5's Major Role in Golgi Fragmentation in Alzheimer's Disease Mol. Biol. Cell, July 1, 2008; 19(7): 3052 - 3069. [Abstract] [Full Text] [PDF]

				K. Sawai, M. Mukoyama, K. Mori, M. Kasahara, M. Koshikawa, H. Yokoi, T. Yoshioka, Y. Ogawa, A. Sugawara, H. Nishiyama, et al. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1363 - F1372. [Abstract] [Full Text] [PDF]

				E. Bertelli, M. Regoli, L. Fonzi, R. Occhini, S. Mannucci, L. Ermini, and P. Toti Nestin Expression in Adult and Developing Human Kidney J. Histochem. Cytochem., April 1, 2007; 55(4): 411 - 421. [Abstract] [Full Text] [PDF]

				Y. Chang, P. Ostling, M. Akerfelt, D. Trouillet, M. Rallu, Y. Gitton, R. El Fatimy, V. Fardeau, S. Le Crom, M. Morange, et al. Role of heat-shock factor 2 in cerebral cortex formation and as a regulatorof p35 expression. Genes & Dev., April 1, 2006; 20(7): 836 - 847. [Abstract] [Full Text] [PDF]

				R. V. Durvasula and S. J. Shankland Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis Am J Physiol Renal Physiol, September 1, 2005; 289(3): F577 - F584. [Abstract] [Full Text] [PDF]